Download presentation
Presentation is loading. Please wait.
1
An infant with yellowish skin
Case Discussion An infant with yellowish skin Presenter: intern 傅蓓安 Date: 2016/03/31
2
Basic Information Chief complaint Name: 許O涓之女 Chart No.: 1771XXXX
Age: 1 day old Date of admission: 2016/07/29 Chief complaint Dyspnea at birth
3
No maternal comorbidities prenatal care uneventful
07/29 07:47 Born to a 19-year-old mother G1P1, GA 36+3, PPROM, NSD Apgar score 9 10 BBW 2272gm(10-25 percentile) BH 46.2 cm(25-50 percentile) HC 30.5 cm(<10 percentile) No maternal comorbidities prenatal care uneventful Subcostal retraction, tachypnea PEEP with neopuff O2 3-5L/min, SpO2 >90%
4
Physical Examination Conjunctiva not pale, sclera anicteric
Neck: no jugular vein engorgement Chest: Symmetric expansion, bilateral clear breathing sound, crackles(-), wheezing (-) Heart: regular heart beat, murmur(-) Extremities: no pitting edema, no cyanosis
5
Family History
6
Lab 9~30 13.5~22.0 98~118 150~350 CRP: 7.3 mg/L
7
CXR (AP) Impression: respiratory distress syndrome, grade I
8
Tentative diagnosis Respiratory distress syndrome, grade I A+P
Micro-lab f/u Bubble CPAP Empirical antibiotics: ampicillin+gentamycin
9
AST/ALT 48/10 albumin 3.5 (B/A ratio 5.4) Ca 8.4, K 3.1 LD 706
07/29 (05:30) Bilirubin (direct/total): 0.2/18.9 3 lamps of phototherapy + IVF transferred to NICU at 07: gave 5 lamps of phototherapy etiology survey bilirubin f/u Q4H AST/ALT 48/10 albumin 3.5 (B/A ratio 5.4) Ca 8.4, K 3.1 LD 706 07/30 morning Bilirubin (direct/total): (09:06)1.6/18.1 (13:05) 18.6
10
Pediatrics 114.1 (2004): 297.
11
Keep intensive phototherapy
07/29 Blood exchange transfusion(BET) - pre-BET survey finished - umbilical vein CVC inserted - umbilical artery CVC failed peripheral arterial line - brain echo: no IVH - transfusion: 15:30-17: ml/cycle, 3min/cycle, 38 cycles 07/30 morning 07/30 14:30 Bilirubin (direct/total) f/u 1hr: 0.4/13.9 4hr: 1.0/ hr: 1.1/13.0 Keep intensive phototherapy
12
Bilirubin level lowering: (07/31) 13.5 (08/02) 10.6
07/29 Bilirubin level lowering: (07/31) 13.5 (08/02) 10.6 07/30 morning HDN investigation: - baby: type A, Rh +, direct Coomb’s test (+, trace), Ab screening test (-) - mother: type O, Rh +, direct Coomb’s test (-) 07/30 14:30 07/31 -08/02 G6PD 24.1 U/g Hb ( ) Blood culture: negtive HSV IgM & IgG(-), toxoplasma IgG(-) CMV(-), RPR/VDRL(-) Transferred to level II on 08/02
13
Bilirubin level lowering
07/29 07/30 morning 07/30 14:30 Bilirubin level lowering Hyperkalemia: (08/03) 7.02 6.5 5.9 (08/04) 6.92 6.32 With +~++ hemolysis EKG: normal keep bricanyl 0.2amp Q6H 08/01 -08/02 08/03 -08/05
14
Persistent hyperkalemia Persistent +~++ hemolysis
07/29 07/30 morning 07/30 14:30 08/01 -08/02 08/03 -08/05 Persistent hyperkalemia Persistent +~++ hemolysis (08/08) micro K 5.84, bil-T 8.7 MBD on 08/08 08/06 -08/08
15
Discussion blood exchange transfusion
16
Pediatrics 114.1 (2004): 297.
17
If TSB level meets the transfusion level or TSB ≧ 25mg/dL
or TSB≧ 20mg/dL in sick or GA<38 infant Request blood for possible exchange transfusion Intensive phototherapy If infant with isoimmune hemolytic diseases, and (1) TSB rise despite phototherapy (2) Within 2-3mg/dL of exchange level IVIG 0.5-1g/kg over 2hr, repeat in 12hr if necessary
18
If TSB (1)not decreasing (2)Moving toward exchange transfusion level (3)B/A ratio high Blood exchange transfusion
19
Double volumn BET + continue phototherapy
Intensive phototherapy Prepare for BET ABE STB in Exchange zone STB↓ in 3-4hr STB>25 PT AAP’s guideline STB in PT zone Intensive phototherapy STB<2mg Of exchange STB below PT zone STB f/u After 12hr Seminars in perinatology, Vol. 35, No. 3, pp
20
Blood exchange transfusion
Remove circulating antibody coated red blood cells and hemolytic products Wash out unconjugated bilirubin Provide fresh donor albumin with Bilirubin binding site
21
Choice and use of donor blood
Cross-matched “fresh” (< 5days) to avoid hyperkalemia pRBC:FFP=3:1, FFP from AB blood type Saline wash, irradiation, warmed
22
Umbilical arteries & vein Peripheral vessels
Umbilical arteries & vein Peripheral vessels
23
Peripheral vessels access
Pros: temperature regulation, less GI complication, could applied in any stage Cons: local limb ischemia, tendency of occlusion Pediatrics 2008;122;e905
24
Volumn & Rate Estimated blood volumn: 80-90ml/kg - SVBET: exchange 63% of blood - DVBET: exchange 86% of blood Bilirubin removed was 45% higher than the fall in serum bilirubin Body weight ml/cycle <1500gm 5ml 1500~2500gm 10ml gm 15ml >3500gm 20ml
25
Adverse events Mortality rate: % - necrotizing enterocolitis - cardiovascular collapse - sepsis Adverse event rate: 6.7% mostly resolve in 48hr 100ml blood + 1ml calcium gluconate [1]J Pediatr 2004;144:626-31; [2] Pediatrics 1997;99;e7
26
Thank You!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.